Governments seek buyer as Quebec COVID-19 vaccine manufacturer Medicago set to close
The Quebec government says it's looking to find a buyer for Medicago Inc., the Quebec-based COVID-19 vaccine manufacturer that will be shut down by parent company Mitsubishi Chemical.
Quebec Economy Minister Pierre Fitzgibbon said Friday the province has had preliminary talks with potential buyers in the pharmaceutical sector to keep Medicago's expertise and skilled workforce in Quebec.
He said both the Quebec and federal governments would be willing to put in money to secure a deal.
"We can't operate it ourselves; the government will not be the main shareholder," Fitzgibbon said. "But if there is a pharmaceutical company that considers it's worth continuing, we're ready to help."
Mitsubishi Chemical said Thursday it would stop marketing the Medicago-produced Covifenz vaccine, which is plant-based and was approved by Health Canada one year ago for adults aged 18 to 64.
The Japanese chemical company said it had been preparing to commercially produce the Covifenz vaccine but decided against doing so because of the "significant changes" in the COVID-19 vaccine environment.
The company said it would dissolve Medicago because it is no longer "viable" to continue marketing its products.
"In light of significant changes to the COVID-19 vaccine landscape since the approval of Covifenz, and after a comprehensive review of the current global demand and market environment for COVID-19 vaccines and Medicago’s challenges in transitioning to commercial-scale production, the (company) has determined that it will not pursue the commercialization of Covifenz," Mitsubishi Chemical said in a statement.
Following the announcement, Medicago issued a statement thanking its employees.
"The Medicago team has pushed scientific boundaries and we know that they will continue to make incredible contributions to innovation and biopharmaceutical’s sector."
Canada invested $173 million in Medicago in 2020 to support development of the Covifenz vaccine and help Medicago expand its production facility in Quebec City.
On Thursday, Innovation, Science and Industry Minister François-Philippe Champagne told reporters the federal government is in "solution mode."
"Our first order of business is really to try to find a partner who can help us preserve the jobs, preserve the technology and the intellectual property," Champagne said.
The minister acknowledged that mRNA vaccine technology for COVID-19 became dominant as it "seemed to be most effective."
But Medicago's plant-based vaccine was still "promising," Champagne said.
"Everyone agreed that the plant-based vaccine could very well help in a future pandemic," Champagne said.
Speaking to reporters on Montreal's South Shore Friday, Fitzgibbon said the company informed the province at the end of December it intended to pull the plug on Medicago.
In May 2015, Quebec and Ottawa announced loans of $60 million and $8 million, respectively, for the construction of a complex in the Quebec City region to house Medicago's activities.
"The challenge is not (getting the loan repaid), it's how we can save the jobs, save this company," Fitzgibbon said.
While Canada authorized Medicago's vaccine in February 2022, it was rejected for emergency use by the World Health Organization in March because tobacco company Philip Morris was a minority shareholder in the company, contravening a policy adopted in 2005 by the United Nations agency.
Quebec City Mayor Bruno Marchand said on Twitter he was saddened by the closure of the company.
"My thoughts are with the families who learned some very sad news," Marchand said Thursday evening. "We have to roll up our sleeves to keep all this expertise in the field of health innovation in Quebec City."
This report by The Canadian Press was first published Feb. 3, 2023.
CTVNews.ca Top Stories
'Canada will be absolutely fine': Justin Trudeau, his ministers and Pierre Poilievre congratulate Donald Trump
Canadian Prime Minister Justin Trudeau and members of his cabinet congratulated Donald Trump Wednesday morning on his second United States presidential election win, amid questions about how the federal government intends to navigate a second term.
What Donald Trump's election victory could mean for Canada
Following president-elect Donald Trump's decisive election victory, there are sure to be significant knock-on effects for Canada. Here's a look at the different areas in which a second Trump presidency may affect Canadians.
Kamala Harris concedes: Here's what she said in her speech
Democratic Vice-President Kamala Harris conceded the U.S. election to Republican Donald Trump Wednesday afternoon, telling her supporters that her 'heart is full.'
Canada orders wind up of TikTok's Canadian business, app access to continue
The federal government is ordering the dissolution of TikTok's Canadian business after a national security review of the Chinese company behind the social media platform, but stopped short of ordering people to stay off the app.
Newfoundland hockey player suspended, banned from local arena after off-ice fight with fan
A combination of a thrown stick and thrown punches have given a senior hockey player in Newfoundland a three-game suspension and an indefinite ban from one of his league's six arenas.
Controversial Australian Olympic breakdancer 'Raygun' retires from competition
Australian breaker Rachael Gunn has told a Sydney radio station that she plans to retire from competition just three months after her unconventional routine at the Paris Olympics led to her being ridiculed and spawned conspiracy theories about how she qualified for the Games.
Sleepy during the day? You may be at higher risk for a pre-dementia syndrome, study finds
If you find yourself sleepy during your daily activities in your older age, you may need to consider it more than an inconvenience — since the fatigue may indicate you’re at higher risk for developing a condition that can lead to dementia, a new study has found.
Kamala Harris made a historic dash for the White House. Here's why she fell short.
"Sometimes the fight takes a while. That doesn't mean we won't win," U.S. Vice-President Kamala Harris said on Wednesday in her concession speech.
Who won the popular vote? U.S. election vote totals from the past 40 years
Donald Trump won the U.S. presidency on Tuesday, and as of Wednesday morning, was also ahead in the popular vote. Historically, though, the candidate with the most votes hasn’t always won the contest.